COMBINED SODIUM FLUORIDE AND CALCIUM CITRATE THERAPY IN OSTEOPOROSIS

氟化钠和柠檬酸钙联合治疗骨质疏松症

• 批准号: 6567706
• 负责人: KHASHAYAR SAKHAEE
• 金额: $ 32.14万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-12-01 至 2002-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6567706
• 关键词: calcium; citrates; clinical research; clinical trials; combination chemotherapy; fluorine; human subject; human therapy evaluation; metabolism disorder chemotherapy; osteoporosis; skeletal disorder chemotherapy; slow release drug; sodium

The purpose is to determine whether or not the amount of bone in persons suffering from osteoporosis can be increased using a combination of slow release sodium fluoride and calcium citrate. Since this is a non- randomized study, only previously entered patients continue to be studied. New patients are entered into the randomized trials underway via sister projects.

其目的是确定人体内的骨量 患有骨质疏松症的人可以使用慢速的组合 释放氟化钠和柠檬酸钙。因为这是一个非- 随机研究，只有先前进入的患者继续 学习。新的患者被纳入正在进行的随机试验 通过姊妹项目。